NY-ESO-1 T cells for the treatment of synovial sarcoma

featured image
Indications: Soft tissue sarcoma
Therapeutic Areas: Sarcoma
Year: 2017

NY-ESO-1 T cells are genetically modified T cells that are re-infused into the patient. It is being developed for the treatment of cancers including melanoma, multiple myeloma and synovial sarcoma. It is currently in Phase III clinical trials.